Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Use of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic inpatients: A recommendation statement from the University of Pennsylvania Health System Center for Evidence-based Practice.

BIBLIOGRAPHIC SOURCE(S)

  • Agarwal R, Carpenter J, Davis J, Hanson CW, Iyoob S, Langer J, Maloney-Wilensky E, Mohler E, Reilly P, Umscheid CA, Wernsing D, Williams K, University of Pennsylvania Health System Ultrasound Task Force. Use of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic inpatients: a recommendation statement from the University of Pennsylvania Health System Center for Evidence-based Practice. Philadelphia (PA): University of Pennsylvania Health System; 2007 Feb 21. 39 p. [38 references]

GUIDELINE STATUS

This is the current release of the guideline.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Definitions for the quality of evidence (high, moderate, low, very low) and strength of recommendations (strong, weak, further research) are repeated at the end of the Major Recommendations.

Use of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients

  1. Routine thromboprophylaxis instead of ultrasound surveillance should be the cornerstone of venous thromboembolic event (VTE) prevention in asymptomatic inpatients. The Anticoagulation Task Force provides guidelines for routine thromboprophylaxis. (Strong Recommendation, Moderate to Low Quality Evidence)
  2. Ultrasound surveillance of the bilateral proximal lower extremities may be most appropriate in situations where thromboprophylaxis is not possible. (Weak Recommendation, Very Low Quality Evidence)
  3. Ultrasound surveillance of the bilateral proximal lower extremities may also be appropriate in patients at the highest risk of deep venous thrombosis (DVT) or pulmonary embolism (PE) despite thromboprophylaxis (i.e., spinal cord injury patients, major trauma patients with high severity scores, and the highest risk orthopedic patients), and should likely be performed no more frequently than approximately once weekly. (Weak Recommendation, Very Low Quality Evidence)
  4. Color duplex ultrasound has adequate sensitivity and specificity to diagnose DVT in asymptomatic inpatients, and should be the test of choice for the diagnosis of DVT in asymptomatic inpatients when compared with D-Dimer assays or risk scores based on history and physical. (Strong Recommendation, Moderate Quality Evidence)
  5. D-Dimer assays should not be used to diagnose DVT in asymptomatic inpatients. (Strong Recommendation, Moderate Quality Evidence)

Definitions:

Quality of Evidence

The following grades of overall quality developed by the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) working group were used to grade the overall quality of evidence for each outcome:

High - Further research is very unlikely to change confidence in the estimate of effect

Moderate - Further research is likely to impact confidence in the estimate of effect and may change the estimate

Low - Further research is very likely to impact confidence in the estimate of effect and is likely to change the estimate

Very low - Any estimate of effect is very uncertain

Strength of Recommendations

Strong - Test should or should not be used for routine surveillance of deep venous thrombosis (DVT)

Weak - Test may be useful for surveillance of DVT in certain circumstances

Further research - No evidence exists for the usefulness of test in surveillance of DVT

CLINICAL ALGORITHM(S)

None provided

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of supporting evidence is identified and graded for each recommendation (see "Major Recommendations").

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Agarwal R, Carpenter J, Davis J, Hanson CW, Iyoob S, Langer J, Maloney-Wilensky E, Mohler E, Reilly P, Umscheid CA, Wernsing D, Williams K, University of Pennsylvania Health System Ultrasound Task Force. Use of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic inpatients: a recommendation statement from the University of Pennsylvania Health System Center for Evidence-based Practice. Philadelphia (PA): University of Pennsylvania Health System; 2007 Feb 21. 39 p. [38 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2007 Feb

GUIDELINE DEVELOPER(S)

University of Pennsylvania Health System - Academic Institution

SOURCE(S) OF FUNDING

University PA Health System

GUIDELINE COMMITTEE

University of Pennsylvania Health System (UPHS) Ultrasound Task Force

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Rajender Agarwal, Jeffery Carpenter, Julia Davis, C. William Hanson, Suzanne Iyoob, Jill Langer, Eileen Maloney-Wilensky, Emile Mohler, Pat Reilly, Craig A. Umscheid, David Wernsing, Kendal Williams

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Voting members of the Task Force were free of conflicts of interest.

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

AVAILABILITY OF COMPANION DOCUMENTS

None available

PATIENT RESOURCES

None available

NGC STATUS

This NGC summary was completed by ECRI Institute on April 2, 2008. The information was verified by the guideline developer on April 30, 2008.

COPYRIGHT STATEMENT

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo